[Form 4] Eli Lilly & Co. Insider Trading Activity
Juan R. Luciano, a director of Eli Lilly & Co. (LLY), reported an acquisition on 08/18/2025 recorded on a Form 4. The filing shows a Code V transaction (shares acquired pursuant to a plan) and lists 16,403.184 as the amount of securities beneficially owned following the reported transaction. The filing also references $698.05 and includes an explanatory note that the shares acquired were deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in common stock after the reporting person鈥檚 separation from service.
Juan R. Luciano, membro del consiglio di amministrazione di Eli Lilly & Co. (LLY), ha segnalato un acquisto il 18/08/2025 mediante un Modulo 4. La comunicazione indica una transazione di Codice V (azioni acquisite ai sensi di un piano) e riporta 16.403,184 come numero di titoli di cui beneficia dopo l鈥檕perazione segnalata. Nel documento 猫 inoltre citato l鈥檌mporto di $698.05 e viene spiegato che le azioni ottenute sono state differite in luogo della remunerazione in contanti come unit脿 azionarie ai sensi del Lilly Directors' Deferral Plan e saranno liquidate in azioni ordinarie dopo la cessazione del rapporto del dichiarante.
Juan R. Luciano, director de Eli Lilly & Co. (LLY), notific贸 una adquisici贸n el 18/08/2025 registrada en un Formulario 4. La presentaci贸n muestra una transacci贸n de C贸digo V (acciones adquiridas conforme a un plan) y refleja 16.403,184 como la cantidad de valores de los que es beneficiario tras la operaci贸n reportada. El documento tambi茅n menciona $698.05 e incluye la aclaraci贸n de que las acciones adquiridas se diferieron en lugar del pago en efectivo como unidades de acciones bajo el Lilly Directors' Deferral Plan y se liquidar谩n en acciones ordinarias despu茅s de la separaci贸n del informante del servicio.
鞐橂Μ 毽措Μ 鞎� 旎错嵓雼�(Eli Lilly & Co., LLY) 鞚挫偓鞚� 頉勳晥 R. 耄箻鞎勲吀電� 2025雲� 8鞗� 18鞚检棎 鞏戩嫕(Form) 4鞐� 旮办灛霅� 旆摑鞚� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖 靹滊電� 瓿勴殟鞐� 霐半ジ 旆摑鞚� 鞚橂頃橂姅 旖旊摐 V 瓯半灅搿� 響滌嫓霅橂┌, 氤搓碃霅� 瓯半灅 鞚错泟鞚� 鞁れ唽鞙� 歃濌秾 靾橂ゼ 16,403.184搿� 旮办灛頃橁碃 鞛堨姷雼堧嫟. 靹滊鞐愲姅 霕愴暅 $698.05臧� 鞏戈笁霅橃柎 鞛堨溂氅�, 旆摑頃� 欤检嫕鞚� 順勱笀 氤挫垬 雽�鞁� Lilly Directors' Deferral Plan鞐� 霐半澕 欤检嫕 雼渼搿� 鞚挫棸霅橃棃瓿� 鞁犼碃鞚胳潣 韲挫 鞁� 氤错喌欤茧 鞝曥偘霅滊嫟電� 靹る獏鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Juan R. Luciano, administrateur d'Eli Lilly & Co. (LLY), a d茅clar茅 une acquisition le 18/08/2025 enregistr茅e sur un formulaire 4. Le dossier indique une op茅ration de Code V (actions acquises en vertu d'un plan) et affiche 16.403,184 comme le nombre de titres dont il b茅n茅ficie suite 脿 la transaction d茅clar茅e. Le d茅p么t fait 茅galement r茅f茅rence 脿 $698.05 et pr茅cise que les actions acquises ont 茅t茅 diff茅r茅es en lieu et place d'une r茅mun茅ration en esp猫ces sous forme d'unit茅s d'actions au titre du Lilly Directors' Deferral Plan et seront r茅gl茅es en actions ordinaires apr猫s la cessation de service de la personne d茅clarante.
Juan R. Luciano, ein Direktor von Eli Lilly & Co. (LLY), meldete am 18.08.2025 einen Erwerb in einer Form 4. Die Einreichung weist eine Transaktion mit Code V aus (Aktien, die gem盲脽 einem Plan erworben wurden) und nennt 16.403,184 als Anzahl der nach der gemeldeten Transaktion wirtschaftlich gehaltenen Wertpapiere. In der Meldung wird au脽erdem $698.05 angegeben und darauf hingewiesen, dass die erworbenen Aktien statt Barauszahlung als Aktienanteile unter dem Lilly Directors' Deferral Plan aufgeschoben wurden und nach dem Ausscheiden der meldenden Person in Stammaktien ausgeglichen werden.
- Director deferral into equity (shares were deferred in lieu of cash under the Lilly Directors' Deferral Plan), which aligns executive compensation with shareholder interests
- Transparent reporting of the transaction by filing Form 4 and providing an explanatory note specifying settlement will occur after separation from service
- None.
Insights
TL;DR: Director Luciano reported a deferred stock-unit acquisition under the director deferral plan; ownership after the transaction is 16,403.184 shares.
The Form 4 documents a Code V acquisition on 08/18/2025, indicating compensation-related deferral rather than open-market buying or option exercise. The filing lists 16,403.184 shares as beneficially owned following the transaction and references $698.05. This is a routine insider reporting of director compensation deferral with no explicit change to outstanding derivative positions disclosed.
TL;DR: This is a standard director deferral disclosure showing compensation converted to deferred stock units to be settled later.
The explanatory note clarifies the economic nature of the transaction: shares were deferred in lieu of cash under the Lilly Directors' Deferral Plan and will be converted to common stock upon separation from service. Such filings typically reflect alignment of director compensation with shareholder equity, and the Form 4 signature block shows the filing was made by an authorized representative on 08/19/2025.
Juan R. Luciano, membro del consiglio di amministrazione di Eli Lilly & Co. (LLY), ha segnalato un acquisto il 18/08/2025 mediante un Modulo 4. La comunicazione indica una transazione di Codice V (azioni acquisite ai sensi di un piano) e riporta 16.403,184 come numero di titoli di cui beneficia dopo l鈥檕perazione segnalata. Nel documento 猫 inoltre citato l鈥檌mporto di $698.05 e viene spiegato che le azioni ottenute sono state differite in luogo della remunerazione in contanti come unit脿 azionarie ai sensi del Lilly Directors' Deferral Plan e saranno liquidate in azioni ordinarie dopo la cessazione del rapporto del dichiarante.
Juan R. Luciano, director de Eli Lilly & Co. (LLY), notific贸 una adquisici贸n el 18/08/2025 registrada en un Formulario 4. La presentaci贸n muestra una transacci贸n de C贸digo V (acciones adquiridas conforme a un plan) y refleja 16.403,184 como la cantidad de valores de los que es beneficiario tras la operaci贸n reportada. El documento tambi茅n menciona $698.05 e incluye la aclaraci贸n de que las acciones adquiridas se diferieron en lugar del pago en efectivo como unidades de acciones bajo el Lilly Directors' Deferral Plan y se liquidar谩n en acciones ordinarias despu茅s de la separaci贸n del informante del servicio.
鞐橂Μ 毽措Μ 鞎� 旎错嵓雼�(Eli Lilly & Co., LLY) 鞚挫偓鞚� 頉勳晥 R. 耄箻鞎勲吀電� 2025雲� 8鞗� 18鞚检棎 鞏戩嫕(Form) 4鞐� 旮办灛霅� 旆摑鞚� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖 靹滊電� 瓿勴殟鞐� 霐半ジ 旆摑鞚� 鞚橂頃橂姅 旖旊摐 V 瓯半灅搿� 響滌嫓霅橂┌, 氤搓碃霅� 瓯半灅 鞚错泟鞚� 鞁れ唽鞙� 歃濌秾 靾橂ゼ 16,403.184搿� 旮办灛頃橁碃 鞛堨姷雼堧嫟. 靹滊鞐愲姅 霕愴暅 $698.05臧� 鞏戈笁霅橃柎 鞛堨溂氅�, 旆摑頃� 欤检嫕鞚� 順勱笀 氤挫垬 雽�鞁� Lilly Directors' Deferral Plan鞐� 霐半澕 欤检嫕 雼渼搿� 鞚挫棸霅橃棃瓿� 鞁犼碃鞚胳潣 韲挫 鞁� 氤错喌欤茧 鞝曥偘霅滊嫟電� 靹る獏鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Juan R. Luciano, administrateur d'Eli Lilly & Co. (LLY), a d茅clar茅 une acquisition le 18/08/2025 enregistr茅e sur un formulaire 4. Le dossier indique une op茅ration de Code V (actions acquises en vertu d'un plan) et affiche 16.403,184 comme le nombre de titres dont il b茅n茅ficie suite 脿 la transaction d茅clar茅e. Le d茅p么t fait 茅galement r茅f茅rence 脿 $698.05 et pr茅cise que les actions acquises ont 茅t茅 diff茅r茅es en lieu et place d'une r茅mun茅ration en esp猫ces sous forme d'unit茅s d'actions au titre du Lilly Directors' Deferral Plan et seront r茅gl茅es en actions ordinaires apr猫s la cessation de service de la personne d茅clarante.
Juan R. Luciano, ein Direktor von Eli Lilly & Co. (LLY), meldete am 18.08.2025 einen Erwerb in einer Form 4. Die Einreichung weist eine Transaktion mit Code V aus (Aktien, die gem盲脽 einem Plan erworben wurden) und nennt 16.403,184 als Anzahl der nach der gemeldeten Transaktion wirtschaftlich gehaltenen Wertpapiere. In der Meldung wird au脽erdem $698.05 angegeben und darauf hingewiesen, dass die erworbenen Aktien statt Barauszahlung als Aktienanteile unter dem Lilly Directors' Deferral Plan aufgeschoben wurden und nach dem Ausscheiden der meldenden Person in Stammaktien ausgeglichen werden.
FAQ
What transaction did Juan R. Luciano report on Form 4 for LLY?
How many shares does the filing show beneficially owned after the transaction?
Will the deferred shares be issued immediately?
Does the Form 4 indicate this was an open-market purchase or exercise?
Who signed the Form 4 filing for Juan R. Luciano?
